Psychological Distress of Adult Patients Consulting a Center for Rare and Undiagnosed Diseases: a Cross-sectional Study

Overview

Journal Orphanet J Rare Dis

Publisher Biomed Central

Specialty General Medicine

Date 2023 Apr 14

PMID 37060005

Authors

Meike Mund

Natalie Uhlenbusch

Franziska Rillig

Christina Weiler-Normann

Theresia Herget

Christian Kubisch

Bernd Lowe

Christoph Schramm

Affiliations

Soon will be listed here.

Abstract

Background: Centers for rare diseases serve as contact points for patients with complex, often undiagnosed complaints and persistent somatic symptoms of heterogeneous origin. Little is known about psychological distress of patients consulting these centers.

Objectives: To better understand psychological distress of adult patients presenting at a center for rare diseases by determining the proportion of patients screening positive for depressive, anxiety, and somatic symptom disorders (SSD) and to identify factors associated with increased psychopathology.

Methods: Cross-sectional data from the routine care registry of the Martin Zeitz Center for Rare Diseases (MZCSE) at the University Medical Center Hamburg-Eppendorf in Germany was retrieved and analyzed. We included all adult patients presenting between October 01,2020 and September 30,2021, who gave written informed consent.

Measures: Sociodemographic variables, medical history and healthcare utilization, as well as validated measures to screen for a depressive disorder (PHQ-8), an anxiety disorder (GAD-7), and SSD (PHQ-15, SSD-12).

Results: N = 167 patients were included (age 44.5 ± 14.3 years, 64.7% female). A total of 40.7% of the patients screened positive for a depressive disorder (PHQ-8 ≥ 10), 27.5% for an anxiety disorder (GAD-7 ≥ 10) and 45.0% screened positive for SSD (PHQ-15 ≥ 9 & SSD-12 ≥ 23). Factors associated with increased psychopathology included the number of symptoms, the number of different specialties consulted before and past psychotherapy.

Conclusions: Patients presenting at centers for rare diseases are likely to experience high rates of psychological distress. Systematically screening patients with rare and undiagnosed diseases for mental disorders can help to detect those at risk at an early stage and initiate adequate psychological care.

Citing Articles

Descriptive epidemiology demonstrating the All of Us database as a versatile resource for the rare and undiagnosed disease community.

Magee D, Kicker S, Thomas A J Am Med Inform Assoc. 2024; 32(3):579-585.

PMID: 39715481 PMC: 11833481. DOI: 10.1093/jamia/ocae241.

Measurement Properties of the Patient Health Questionnaire-15 and Somatic Symptom Scale-8: A Systematic Review and Meta-Analysis.

Hybelius J, Kosic A, Salomonsson S, Wachtler C, Wallert J, Nordin S JAMA Netw Open. 2024; 7(11):e2446603.

PMID: 39565620 PMC: 11579800. DOI: 10.1001/jamanetworkopen.2024.46603.

Nature-based interventions for individuals with rare skeletal disorders: evaluation of a 5-day sailing program on health-related quality of life.

Boarini M, Romeo A, Banchelli F, Grippa E, Forni S, la Forgia M Sci Rep. 2024; 14(1):26339.

PMID: 39487306 PMC: 11530639. DOI: 10.1038/s41598-024-77934-1.

Boarini M, Tremosini M, Di Cecco A, Gnoli M, Brizola E, Mordenti M Qual Life Res. 2024; 33(5):1323-1334.

PMID: 38457053 PMC: 11045590. DOI: 10.1007/s11136-024-03604-4.

Reliability and Validity of the Korean Version of the Somatic Symptom Disorder-B Criteria Scale in a Clinical Population.

Jung S, Shin J, Lee S, Lee S, Kim J, Son K Psychiatry Investig. 2024; 21(2):165-173.

PMID: 38433415 PMC: 10910159. DOI: 10.30773/pi.2023.0352.

References

Lowe B, Levenson J, Depping M, Husing P, Kohlmann S, Lehmann M . Somatic symptom disorder: a scoping review on the empirical evidence of a new diagnosis. Psychol Med. 2021; 52(4):632-648. PMC: 8961337. DOI: 10.1017/S0033291721004177. View

Bauerle A, Teufel M, Musche V, Weismuller B, Kohler H, Hetkamp M . Increased generalized anxiety, depression and distress during the COVID-19 pandemic: a cross-sectional study in Germany. J Public Health (Oxf). 2020; 42(4):672-678. PMC: 7454766. DOI: 10.1093/pubmed/fdaa106. View

Sanchez-Garcia J, Cortes-Martin J, Rodriguez-Blanque R, Marin-Jimenez A, Montiel-Troya M, Diaz-Rodriguez L . Depression and Anxiety in Patients with Rare Diseases during the COVID-19 Pandemic. Int J Environ Res Public Health. 2021; 18(6). PMC: 8003983. DOI: 10.3390/ijerph18063234. View

Toussaint A, Murray A, Voigt K, Herzog A, Gierk B, Kroenke K . Development and Validation of the Somatic Symptom Disorder-B Criteria Scale (SSD-12). Psychosom Med. 2015; 78(1):5-12. DOI: 10.1097/PSY.0000000000000240. View

Toussaint A, Husing P, Kohlmann S, Lowe B . Detecting DSM-5 somatic symptom disorder: criterion validity of the Patient Health Questionnaire-15 (PHQ-15) and the Somatic Symptom Scale-8 (SSS-8) in combination with the Somatic Symptom Disorder - B Criteria Scale (SSD-12). Psychol Med. 2019; 50(2):324-333. DOI: 10.1017/S003329171900014X. View

Hinz A, Ernst J, Glaesmer H, Brahler E, Rauscher F, Petrowski K . Frequency of somatic symptoms in the general population: Normative values for the Patient Health Questionnaire-15 (PHQ-15). J Psychosom Res. 2017; 96:27-31. DOI: 10.1016/j.jpsychores.2016.12.017. View

Kroenke K, Spitzer R, Williams J . The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms. Psychosom Med. 2002; 64(2):258-66. DOI: 10.1097/00006842-200203000-00008. View

Klaus K, Rief W, Brahler E, Martin A, Glaesmer H, Mewes R . The distinction between "medically unexplained" and "medically explained" in the context of somatoform disorders. Int J Behav Med. 2012; 20(2):161-71. DOI: 10.1007/s12529-012-9245-2. View

von der Lippe C, Diesen P, Feragen K . Living with a rare disorder: a systematic review of the qualitative literature. Mol Genet Genomic Med. 2017; 5(6):758-773. PMC: 5702559. DOI: 10.1002/mgg3.315. View

10.

von Elm E, Altman D, Egger M, Pocock S, Gotzsche P, Vandenbroucke J . The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. Int J Surg. 2014; 12(12):1495-9. DOI: 10.1016/j.ijsu.2014.07.013. View

11.

Spitzer R, Kroenke K, Williams J, Lowe B . A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006; 166(10):1092-7. DOI: 10.1001/archinte.166.10.1092. View

12.

Schram M, Baan C, Pouwer F . Depression and quality of life in patients with diabetes: a systematic review from the European depression in diabetes (EDID) research consortium. Curr Diabetes Rev. 2009; 5(2):112-9. PMC: 2764861. DOI: 10.2174/157339909788166828. View

13.

Escobar J, Cook B, Chen C, Gara M, Alegria M, Interian A . Whether medically unexplained or not, three or more concurrent somatic symptoms predict psychopathology and service use in community populations. J Psychosom Res. 2010; 69(1):1-8. PMC: 2905311. DOI: 10.1016/j.jpsychores.2010.01.001. View

14.

Hauser W, Hausteiner-Wiehle C, Henningsen P, Brahler E, Schmalbach B, Wolfe F . Prevalence and overlap of somatic symptom disorder, bodily distress syndrome and fibromyalgia syndrome in the German general population: A cross sectional study. J Psychosom Res. 2020; 133:110111. DOI: 10.1016/j.jpsychores.2020.110111. View

15.

Llubes-Arria L, Sanroma-Ortiz M, Torne-Ruiz A, Carillo-Alvarez E, Garcia-Exposito J, Roca J . Emotional experience of the diagnostic process of a rare disease and the perception of support systems: A scoping review. J Clin Nurs. 2021; 31(1-2):20-31. DOI: 10.1111/jocn.15922. View

16.

Mueller T, Jerrentrup A, Bauer M, Fritsch H, Schaefer J . Characteristics of patients contacting a center for undiagnosed and rare diseases. Orphanet J Rare Dis. 2016; 11(1):81. PMC: 4915144. DOI: 10.1186/s13023-016-0467-2. View

17.

Joustra M, Janssens K, Bultmann U, Rosmalen J . Functional limitations in functional somatic syndromes and well-defined medical diseases. Results from the general population cohort LifeLines. J Psychosom Res. 2015; 79(2):94-9. DOI: 10.1016/j.jpsychores.2015.05.004. View

18.

Rillig F, Gruters A, Schramm C, Krude H . The Interdisciplinary Diagnosis of Rare Diseases. Dtsch Arztebl Int. 2022; 119(27-28):469-475. PMC: 9664985. DOI: 10.3238/arztebl.m2022.0219. View

19.

Hulsen T, de Vlieg J, Alkema W . BioVenn - a web application for the comparison and visualization of biological lists using area-proportional Venn diagrams. BMC Genomics. 2008; 9:488. PMC: 2584113. DOI: 10.1186/1471-2164-9-488. View

20.

Toussaint A, Riedl B, Kehrer S, Schneider A, Lowe B, Linde K . Validity of the Somatic Symptom Disorder-B Criteria Scale (SSD-12) in primary care. Fam Pract. 2017; 35(3):342-347. DOI: 10.1093/fampra/cmx116. View